Measurement of twenty-one serum steroid profiles by UPLC-MS/MS for the diagnosis and monitoring of congenital adrenal hyperplasia
Open Access
- 1 December 2025
- journal article
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 38, 10-17
Abstract
Congenital adrenal hyperplasia (CAH) represents a group of inherited disorders affecting steroidogenesis. Early and accurate diagnosis is crucial for effective treatment, particularly for preventing adrenal insufficiency and minimizing androgen excess. This study aims to develop and validate an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the simultaneous quantification of 21 steroid hormones, including 11-oxygenated androgens, which are critical for diagnosing and monitoring various forms of CAH. We utilized a microbore column UPLC combined with hydroxylamine derivatization, which enabled excellent chromatographic separation and enhanced sensitivity of all target compounds. The method was evaluated for precision, linearity, recovery, ion suppression, and carryover according to FDA and CLSI guidelines. Steroid profiles from healthy controls and CAH patients were compared using Mann-Whitney tests. The UPLC-MS/MS method demonstrated excellent precision (2 > 0.99), low limits of detection and quantification, and satisfactory recovery (57–86 % absolute, 99–111 % relative). Our method showed good correlation with proficiency testing group means, although significant negative biases were noted for androstenedione, progesterone, and 11-deoxycortisol. In a clinical setting, significant increases in pregnenolone, progesterone, 17-hydroxyprogesterone, dehydroepiandrosterone, and other key steroids were observed in patients with 21-hydroxylase deficiency, while distinct profiles were identified for patients with 17-hydroxylase deficiency, cytochrome P450 oxidoreductase deficiency, and lipoid CAH. Our UPLC-MS/MS method provides a sensitive and specific tool for the comprehensive profiling of adrenal steroids, offering improved diagnostic accuracy for CAH. Its ability to differentiate between various CAH subtypes highlights its potential clinical utility in both diagnosis and monitoring.Keywords
Funding Information
- Seoul National University Hospital (22C-007-0100)
This publication has 20 references indexed in Scilit:
- The clinical and biochemical significance of 11-oxygenated androgens in human health and diseaseEuropean Journal of Endocrinology, 2023
- Congenital adrenal hyperplasiaThe Lancet, 2022
- 21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase DeficiencyThe Journal of Pediatrics, 2022
- A quantitative analysis of total and free 11-oxygenated androgens and its application to human serum and plasma specimens using liquid-chromatography tandem mass spectrometryJournal of Chromatography A, 2021
- Implementing steroid profiling by liquid chromatography‐tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New ZealandClinical Endocrinology, 2021
- Expanding genetic spectrum and discriminatory role of steroid profiling by LC‐MS/MS in 11β‐hydroxylase deficiencyClinical Endocrinology, 2020
- Selective LC-MRM/SIM-MS based profiling of adrenal steroids reveals metabolic signatures of 17α-hydroxylase deficiencyThe Journal of Steroid Biochemistry and Molecular Biology, 2020
- Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-DeoxycortisolHormone Research in Paediatrics, 2019
- Quantitative-Profiling Method of Serum Steroid Hormones by Hydroxylamine-Derivatization HPLC–MSNatural Products and Bioprospecting, 2019
- Resolution and Identification of Steroid Oxime Syn and Antiisomers by HPLCJournal of Liquid Chromatography, 1990